论文部分内容阅读
目的:观察血滞通胶囊辅助治疗脑血栓患者的疗效及安全性,并总结其护理方法。方法:选取110例脑血栓患者为研究对象,随机分为观察组和对照组各55例。对照组患者采用常规治疗方案,观察组在对照组治疗方案的基础上加用血滞通胶囊进行治疗,2组患者均接受康复护理干预。观察比较2组患者疗效情况、脑血流动力学改善情况和脑血栓并发症情况以评价血滞通胶囊的治疗效果。结果:观察组共53例患者完成研究,对照组共51例患者完成研究;治疗后,2组患者神经功能缺损评分均较治疗前改善,差异均有统计学意义(P<0.01),但观察组患者评分优于对照组,差异有统计学意义(P<0.01);治疗后,2组患者全血黏度、血浆黏度和血小板聚集率三项指标均较治疗前改善,差异均有统计学意义(P<0.05),但观察组患者三项指标均优于对照组,差异均有统计学意义(P<0.05,P<0.01);观察组患者并发症发生率1.89%,低于对照组13.72%,差异有统计学意义(P<0.05)。结论:应用血滞通胶囊对脑血栓患者进行辅助治疗可以改善患者神经功能缺损状况和脑血液流变学指标,降低患者脑卒中并发症发生率,是一种安全有效的治疗方法。
Objective: To observe the efficacy and safety of Xue-Li-Tong Capsule in the treatment of cerebral thrombosis and to summarize its nursing methods. Methods: One hundred and thirteen patients with cerebral thrombosis were selected and divided into observation group and control group randomly. Patients in the control group were treated with routine treatment. The observation group was treated with Xue-Li Tong capsule on the basis of the control group, and both groups received rehabilitation nursing intervention. The curative effect, cerebral hemodynamics improvement and cerebral thrombosis complication in two groups were observed and compared to evaluate the therapeutic effect of Xue-Li-Tong capsule. Results: A total of 53 patients in the observation group completed the study. A total of 51 patients in the control group completed the study. After treatment, the neurological deficit scores of both groups were improved compared with those before treatment, with significant differences (P <0.01) The scores of patients in the two groups were significantly better than those in the control group (P <0.01). After treatment, the three indexes of whole blood viscosity, plasma viscosity and platelet aggregation rate in both groups improved compared with that before treatment, and the differences were statistically significant (P <0.05), but the three indexes in the observation group were better than those in the control group (P <0.05, P <0.01). The incidence of complications in the observation group was 1.89%, which was lower than that of the control group %, The difference was statistically significant (P <0.05). Conclusion: The application of Xue-Li-Tong Capsule in patients with cerebral thrombosis adjuvant therapy can improve patients with neurological deficit and cerebral hemorheology indicators, reduce the incidence of stroke complications in patients is a safe and effective treatment.